Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis

Castigliano Bhamidipati, Jay D. Pal, Thomas K. Jones, James M. McCabe, Mark Reisman, Jason W. Smith, Claudius Mahr, Nahush A. Mokadam

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.

Original languageEnglish (US)
Pages (from-to)e101-e104
JournalAnnals of Thoracic Surgery
Volume103
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Transplants
L-Lactate Dehydrogenase
Thrombosis
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Outflow Graft Obstruction Treated With Transcatheter Management : A Novel Therapy for a New Diagnosis. / Bhamidipati, Castigliano; Pal, Jay D.; Jones, Thomas K.; McCabe, James M.; Reisman, Mark; Smith, Jason W.; Mahr, Claudius; Mokadam, Nahush A.

In: Annals of Thoracic Surgery, Vol. 103, No. 1, 01.01.2017, p. e101-e104.

Research output: Contribution to journalArticle

Bhamidipati, Castigliano ; Pal, Jay D. ; Jones, Thomas K. ; McCabe, James M. ; Reisman, Mark ; Smith, Jason W. ; Mahr, Claudius ; Mokadam, Nahush A. / Outflow Graft Obstruction Treated With Transcatheter Management : A Novel Therapy for a New Diagnosis. In: Annals of Thoracic Surgery. 2017 ; Vol. 103, No. 1. pp. e101-e104.
@article{698d0e2103d244eeb9ac4db5d1e3bebf,
title = "Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis",
abstract = "The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.",
author = "Castigliano Bhamidipati and Pal, {Jay D.} and Jones, {Thomas K.} and McCabe, {James M.} and Mark Reisman and Smith, {Jason W.} and Claudius Mahr and Mokadam, {Nahush A.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.athoracsur.2016.07.031",
language = "English (US)",
volume = "103",
pages = "e101--e104",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Outflow Graft Obstruction Treated With Transcatheter Management

T2 - A Novel Therapy for a New Diagnosis

AU - Bhamidipati, Castigliano

AU - Pal, Jay D.

AU - Jones, Thomas K.

AU - McCabe, James M.

AU - Reisman, Mark

AU - Smith, Jason W.

AU - Mahr, Claudius

AU - Mokadam, Nahush A.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.

AB - The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.

UR - http://www.scopus.com/inward/record.url?scp=85006367215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006367215&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2016.07.031

DO - 10.1016/j.athoracsur.2016.07.031

M3 - Article

C2 - 28007258

AN - SCOPUS:85006367215

VL - 103

SP - e101-e104

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -